Studying of psychical adaptation features and peroxide lipids oxidation in patients suffering from community-acquired pneumonia in Belarus prisons Source: Eur Respir J 2006; 28: Suppl. 50, 375s Year: 2006
Community-acquired pneumonia in the prisons of Belarus Source: Eur Respir J 2002; 20: Suppl. 38, 608s Year: 2002
Peculiarities of community-acquired pneumonia in tobacco-smoking patients Source: Annual Congress 2009 - Tobacco: from smoke to disease Year: 2009
Structure of the basic pathogens of bacterial bronchitis and pneumonia in hospitalized patients in Belarus Source: Eur Respir J 2006; 28: Suppl. 50, 4s Year: 2006
Etiology and antibiotic resistance patterns in adults with severe community-acquired pneumonia in Russia Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019
Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012
Late Breaking Abstract - Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by SARS-CoV-2, bacteria, and influenza Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021
Particularities of community-acquired pneumonia in the elderly Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007
Glutathione level in community-acquired pneumonia patients. Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Incidence of community-acquired pneumonia episodes in COPD patients in England and Wales Source: Eur Respir J 2007; 30: Suppl. 51, 628s Year: 2007
Etiology of community-acquired pneumonia (CAP) in young hospital patients Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002
The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010
Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006
Evaluation of thiol/disulfide redox status in community-acquired pneumonia Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017
Ethyology of community-acquired pneumonia in servicemen at the age of 18–21 Source: Eur Respir J 2006; 28: Suppl. 50, 736s Year: 2006
Clinical characteristics of extremely elderly patients with community-acquired and healthcare-associated pneumonia in Japan Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Impact of the phosphatidylcholine treatment program on the respiratory failure in patients with community-acquired pneumonia Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020
The etiological agents of community-acquired pneumonia in our hospital Source: Eur Respir J 2006; 28: Suppl. 50, 735s Year: 2006
Bacteraemia in outpatients with community-acquired pneumonia Source: Eur Respir J 2016; 47: 654-657 Year: 2016